Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ferguson

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular Neurobiology|July 10, 2023
Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite PathologyElly E Liao, Mu Yang, Noah Nathan Kochen, et al.
Molecular Pharmaceutics|May 9, 2020
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer ImmunotherapyHyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2022
Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairsMu Yang, Peter G Larson, Lincoln Brown, et al.
ACS Infectious Diseases|April 18, 2018
Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside ModificationMatthew R Bockman, Curtis A Engelhart, Surendra Dawadi, et al.
Investigational New Drugs|July 27, 2011
Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosisAhmad Raza, Blake A Jacobson, Adam Benoit, et al.
ACS Bio & Med Chem Au|June 26, 2023
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 SignalingNagamani Vunnam, Mu Yang, Chih Hung Lo, et al.
Biomaterials|February 27, 2018
Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapyHyunjoon Kim, Lin Niu, Peter Larson, et al.
European Journal of Pharmacology|December 17, 2008
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase IILisa M Oppegard, Andrei V Ougolkov, Doris N Luchini, et al.
Cancer Chemotherapy and Pharmacology|March 10, 2012
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant gliomaAaron M Teitelbaum, Jose L Gallardo, Jessica Bedi, et al.
Journal of Medicinal Chemistry|February 20, 2019
A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniaeXu Wang, Yuna Zeng, Li Sheng, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular Neurobiology|July 10, 2023
Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite PathologyElly E Liao, Mu Yang, Noah Nathan Kochen, et al.
Molecular Pharmaceutics|May 9, 2020
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer ImmunotherapyHyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2022
Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairsMu Yang, Peter G Larson, Lincoln Brown, et al.
ACS Infectious Diseases|April 18, 2018
Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside ModificationMatthew R Bockman, Curtis A Engelhart, Surendra Dawadi, et al.
Investigational New Drugs|July 27, 2011
Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosisAhmad Raza, Blake A Jacobson, Adam Benoit, et al.
ACS Bio & Med Chem Au|June 26, 2023
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 SignalingNagamani Vunnam, Mu Yang, Chih Hung Lo, et al.
Biomaterials|February 27, 2018
Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapyHyunjoon Kim, Lin Niu, Peter Larson, et al.
European Journal of Pharmacology|December 17, 2008
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase IILisa M Oppegard, Andrei V Ougolkov, Doris N Luchini, et al.
Cancer Chemotherapy and Pharmacology|March 10, 2012
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant gliomaAaron M Teitelbaum, Jose L Gallardo, Jessica Bedi, et al.
Journal of Medicinal Chemistry|February 20, 2019
A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniaeXu Wang, Yuna Zeng, Li Sheng, et al.
Pageof 5